Cargando…

Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers

BACKGROUND: Breast cancer metastasis is a highly prevalent cause of death for European females. DNA microarray analysis has established that primary tumors, which remain localized, differ in gene expression from those that metastasize. Cross-analysis of these studies allow to revile the differences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, R., Barraclough, R., Vasieva, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748874/ https://www.ncbi.nlm.nih.gov/pubmed/28782484 http://dx.doi.org/10.2174/1566524017666170807144946

Ejemplares similares

Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer
por: Thomassen, Mads, et al.
Publicado: (2008)

Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines
por: Moye, V E, et al.
Publicado: (2004)

Functional Analysis of Prognostic Gene Expression Network Genes in Metastatic Breast Cancer Models
por: Geiger, Thomas R., et al.
Publicado: (2014)

Gene expression profile of stromal cells from potential metastatic sites in breast cancer patients
por: Del Valle, Paulo R, et al.
Publicado: (2013)

CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992)

Microarray Analysis of Suppression Subtracted Hybridisation Libraries Identifies Genes Associated with Breast Cancer Progression
por: Barraclough, Dong Liu, et al.
Publicado: (2010)

The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression
por: Adams, Arthur, et al.
Publicado: (2013)

Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells
por: Ruppender, Nazanin S., et al.
Publicado: (2010)

Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells
por: Nikulin, Sergey, et al.
Publicado: (2021)

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
por: Dixon, A. R., et al.
Publicado: (1993)

Potential value of circulatory microRNA10b gene expression and its target E‐cadherin as a prognostic and metastatic prediction marker for breast cancer
por: Dwedar, Fatma Ibrahim, et al.
Publicado: (2021)

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis
por: Tang, Shifu, et al.
Publicado: (2016)

Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers
por: Liu, Xinhua, et al.
Publicado: (2020)

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
por: Pereira-Veiga, Thais, et al.
Publicado: (2021)

In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers
por: Kim, Jongchan
Publicado: (2021)

Gene expression predicts dormant metastatic breast cancer cell phenotype
por: Ren, Qihao, et al.
Publicado: (2022)

Identification of Potential Transcriptomic Markers in Developing Ankylosing Spondylitis: A Meta-Analysis of Gene Expression Profiles
por: Fang, Fang, et al.
Publicado: (2015)

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2012)

Stratification and therapeutic potential of PML in metastatic breast cancer
por: Martín-Martín, Natalia, et al.
Publicado: (2016)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Expression of calcium-binding protein S100A2 in breast lesions
por: Liu, D, et al.
Publicado: (2000)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods
por: Tuo, Youlin, et al.
Publicado: (2018)

Is there a Function for a Sex Pheromone Precursor?: A Predicted Link between Bacterial Redox Metabolism and Propagation of Antibiotic Resistance
por: Vasieva, O., et al.
Publicado: (2019)

A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells
por: Jeffs, Aaron R., et al.
Publicado: (2009)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer
por: Pereira, Jonathas Xavier, et al.
Publicado: (2019)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer
por: Albogami, Sarah
Publicado: (2022)

Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer
por: Lohmann, Ana Elisa, et al.
Publicado: (2018)

Potential for cost economies in guiding therapy in patients with metastatic breast cancer.
por: Robertson, J. F., et al.
Publicado: (1995)

Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.
por: Ke, Y., et al.
Publicado: (1998)

Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival
por: Barraclough, DL, et al.
Publicado: (2006)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Stem cell-related markers in primary breast cancers and associated metastatic lesions
por: Guler, Gulnur, et al.
Publicado: (2012)

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
por: Wirapati, Pratyaksha, et al.
Publicado: (2008)

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
por: Fang, Leiming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmjh97dporekunmaqcv9531obs